Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019

January 30, 2019 — Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing...

Climate Change May Increase Congenital Heart Defects
News | Congenital Heart | January 30, 2019

January 30, 2019 — Rising temperatures stemming from global climate change may increase the number of infants born...

Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

 

Feature | Atrial Fibrillation | January 30, 2019

January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral...

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.

The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.

Feature | Peripheral Artery Disease (PAD) | January 30, 2019 | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat...

FDA Clears Magnetom Lumina 3T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | January 30, 2019

January 30, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T)...

FDA Clears XableCath Crossing Catheters
Technology | Chronic Total Occlusion (CTO) | January 30, 2019

January 30, 2019 — XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the...

Thubrikar Announces First-in-Human Implant of Optimum TAVI System
News | Heart Valve Technology | January 29, 2019

January 29, 2019 — Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their...

Perceval Valve Offers Performance, Economic Advantages in Aortic Disease Treatment
News | Heart Valve Technology | January 29, 2019

January 29, 2019 — LivaNova PLC announced the publication of three separate studies highlighting the performance of...

The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.

The Medtronic Resolute Integrity drug-eluting stent (DES) is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data.

Feature | Stents | January 29, 2019 | Dave Fornell, Editor

There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years...

ACC Hosts Third Annual Cardio-Oncology Course
News | Cardio-oncology | January 28, 2019

January 28, 2019 — The American College of Cardiology host the third...

Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019

January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the...

An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. Advances in angiography imaging.

An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018. 

Feature | Angiography | January 28, 2019 | Dave Fornell, Editor

There are a few recent trends in X-ray...

First Tendyne Transcatheter Mitral Valve Implanted in New York
News | Heart Valve Technology | January 28, 2019

January 28, 2019 — Lenox Hill Hospital is the first hospital in New York City to successfully implant Abbott’s...

Philips Releases Three-Year Data on Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons | January 28, 2019

January 28, 2019 — Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated...

The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.

The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.

Feature | Peripheral Artery Disease (PAD) | January 25, 2019 | Dave Fornell, Editor

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since...

Overlay Init